32 matches for your search in the start-up spotlight
rss
We are a spin-off company out of the Angiology Division of the Lausanne University Hospital (CHUV) and of the Laboratory of Lymphatic and Cancer Bioengineering of the Swiss Federal Institute of Technology in Lausanne (EPFL). Lymphatica Medtech was founded in 2017 by Dr. Triacca and Dr. Pisano, ...
We are an innovative Swiss company that develops laboratory instruments based on a proprietary light scattering technology. Oryl Photonics is a spin-off from École Polytechnique Fédérale de Lausanne (EPFL) where the technology is incubated over a decade of research.
Isospec Analytics is an EPFL spin-off based in Lausanne – Switzerland, whose mission is to implement technology to discover new disease biomarkers, accelerate the development of therapeutics and transform the future of clinical nutrition.
Vandria is at the vanguard of mitochondrial therapeutics. It is developing first-in-class mitophagy inducers that rejuvenate cells to treat age-related and chronic diseases. Its lead program, VNA-318 is a brain-penetrant, patent-protected, mitophagy inducer which has been shown to acutely improve ...
Embion is a chemical process technology EPFL spin-off, commercializing a novel catalytic process that allows the use of sustainable resources in the form of 2nd generation lignocellulosic biomass for producing food ingredients, chemicals and fuels. Our process helps reducing the carbon footprint ...
ActLight SA focuses in the field of CMOS photonics by developing a new type of photodetector. Being a fabless company, ActLight specializes in the Intellectual Property (IP) of this area and provides supporting services like design and technology advice for its customers.
Embion is a chemical process technology EPFL spin-off, commercializing a novel catalytic process that allows the use of sustainable resources in the form of 2nd generation lignocellulosic biomass for producing food ingredients, chemicals and fuels. Our process helps reducing the carbon footprint ...
INNOVATING DRUG DISCOVERY QGel is dedicated to making in vitro drug discovery more relevant to in vivo biology. QGel in vitro assays are physiologically relevant because they are based on clonogenically-grown cells within designer microenvironments that favour the expression of physiological ...
The Alpine Institute for Drug Discovery (AIDD) is an enterprise aiming at creating shared value for the community and working with academic researchers, technology transfer offices and local incubators to commercialise academic discoveries with therapeutic potential. Working in collaboration with ...
